FDA Letter API

21st Century Scientific Inc

Letter data

Company
21st Century Scientific Inc
Recipient
Ronald D. Davidson | Chief Operating Officer | 21st Century Scientific Inc | 4931 N. Manufacturing Way | Coeur d Alene | , | ID | 83815 | United States | rdd@wheelchairs.com
Issue date
2021-11-04
Posted date
Not available
FDA office
Center for Devices and Radiological Health
Subject
Not available
Product
Medical Devices
CMS ID
566834
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER 21st Century Scientific Inc MARCS-CMS 566834 — November 04, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Product: Medical Devices Recipient: Recipient Name Ronald D. Davidson Recipient Title Chief Operating Officer 21st Century Scientific Inc 4931 N. Manufacturing Way Coeur d Alene , ID 83815 United States rdd@wheelchairs.com Issuing Office: Center for Devices and Radiological Health United States Dear Mr. Davidson: The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter dated May 13, 2019. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Jessica Mu, Director, Compliance Branch Office of Medical Devices and Radiological Health, Division III Content current as of: 11/04/2021 Regulated Product(s) Medical Devices